Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P880047/S069

GYNECARE INTERCEED Absorbable Adhesion Barrier

ETHICON, Inc. · Decision date Jan 15, 2026

FDA DECISIONP880047/S069

What did the FDA decide?

FDA records P880047/S069 as a supplement to PMA P880047, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 15, 2026.

FDA approval order statement

a change in foil roll-stock raw material manufactured at AMCOR Flexibles and a supplier address change for AMCOR Flexibles
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Obstetrics/Gynecology
Decision date
Jan 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P880047/S069
Regulatory pathway
PMA supplement
Applicant
ETHICON, Inc.
Product code
MCN
Decision code
OK30
Decision date
Jan 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Barrier, absorbable, adhesion.

Applicant
ETHICON, Inc.
Product code
MCN
FDA device class
3

For the original device and its historical approval scope, see PMA P880047. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P880047 · Original PMA

    INTERCEED TC7 ABSORBABLE ADHESION BARRIER

  2. P880047/S065 · Related supplement

    GYNECARE INTERCEED Absorbable Adhesion Barrier

  3. P880047/S066 · Related supplement

    GYNECARE INTERCEED Absorbable Adhesion Barrier

  4. P880047/S067 · Related supplement

    GYNECARE INTERCEED 3INX4IN(7.6CMX10.2CM); GYNECARE INTERCEED 5INX6IN(12.7CMX15.2CM); GYNECARE INTERCEED 3INX2IN(7.6CMX5.

  5. P880047/S068 · Related supplement

    INTERCEED Absorbable Adhesion Barrier

  6. P880047/S069 received

    Application receipt date recorded by FDA.

  7. P880047/S069 · FDA decision

    30-Day Notice

  8. P880047/S070 · Related supplement

    GYNECARE INTERCEED Absorbable Adhesion Barrier

  9. P880047/S072 · Related supplement

    GYNECARE INTERCEED Absorbable Adhesion Barrier

Timeline entries are records held by MedtechLedger for P880047. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P880047

Explore the linked device profile

Other records with product code MCN

Product / regulatory recordCompanyPathwayDecision dateSource
Rejoni, Inc.PMA supplementOct 28, 2026FDA
Womed LeafP240015/S003
Womed SasPMA supplementOct 25, 2026FDA
Rejoni, Inc.PMA approvalSep 28, 2026FDA
Womed LeafP240015/S002
Womed SasPMA supplementAug 31, 2026FDA
Womed LeafP240015/S001
Womed SasPMA supplementJan 28, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ETHICON, Inc.

Headquarters
Not reported
Brand website
ethicon.com
FDA applicant address
1000 Rte. 202, Raritan, NJ, 08869

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records